Skip to main content

Table 4 Treatment and recurrence (no. of patients, n (%))

From: Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS)—report 4: analysis and outcome of scleritis in an East Asian population

 

Diffuse

Nodular

Necrotizing

Posterior

Number of patients

75 (62.5)

25 (20.8)

7 (5.8)

13 (10.8)

Topical steroids

71 (94.7)

25 (100)

6 (85.7)

12 (92.3)

Oral NSAID

40 (53.3)

16 (64.0)

3 (42.9)

4 (30.8)

Oral corticosteroids

37 (49.3)

9 (36.0)

6 (85.7)

12 (92.3)

Oral immunosuppressives (excluding prednisolone)

19 (25.3)

3 (12.0)

5 (71.4)

5 (38.5)

Oral steroid or immunosuppressives

40 (53.3)

9 (36.0)

6 (85.7)

12 (92.3)

Recurrence

14 (18.7)

2 (8.0)

2 (28.6)

2 (15.4)